SERVICES in Europe
Q1 Scientific Ltd., a Cambrex Company, provides environmentally controlled cGMP stability storage services for the pharmaceutical, medical device, and life science industries.
About the plant
Q1 Scientific Ltd., a Cambrex Company, provides environmentally controlled cGMP stability storage services for the pharmaceutical, medical device, and life science industries.
The state-of-the-art cGMP facility in Waterford provides ICH and custom conditions to meet the specific storage requirements of any pharmaceutical project, with options from -80°C storage up to +50°C, with a full range of humidity control. The facility boasts nearly 40 walk-in stability storage chambers, reach-in freezers and stability units, and ultra-low temperature freezers for biologic therapies. In addition to stability storage services, the team also provides photostability studies, thermal cycling or freeze/thaw studies, and sample management and transport services.
With a team of stability storage experts dedicated to ensuring the integrity and stability of your products, you can focus on developing and bringing innovative solutions to the market.
Compliance
Activity
- SERVICES manufacturing
Features
- Uses: N/A
- Toxicity (OEB classification): N/A
- Controlled substance: N/A
- BSL: N/A
- Therapeutic areas: N/A
- Markets: N/A
Batch Size / Reactor
- N/A
Services
- ICH Stability studies, Logistics, Development services, Storage, Stability studies execution, Stability studies design
Other plants of this company
CHEMICAL-SYNTHETIC SERVICES in Europe Our team in Tallin has strong expertise in custom organic syntheses and contract R&D for pharmaceutical and fine chemical industries.
CHEMICAL-SYNTHETIC in North America Our team members with Snapdragon Chemistry Inc., a Cambrex Company, specialize in chemical process development and manufacturing services, leveraging state-of-the-art technology to optimize your process and prepare scaled quantities of your product.
CHEMICAL-SYNTHETIC in North America Cambrex High Point focuses on the development and manufacture of active pharmaceutical ingredients (APIs) to support clinical trials from Phase I to Phase III, as well as small-scale commercial manufacturing.
